Key Takeaways Centene trades at 13.25X forward P/E, below the industry average but above its five-year median.Medical costs drove HBR to 93% and margins red, with 2025 EPS view cut to $1.75.Commercial membership rose over 30%, but Medicare and Medicaid declines continue to weigh.Centene Corporation (CNC) , a leading player in government-sponsored healthcare, finds itself grappling with the same pressures weighing on the broader industry, elevated utilization rates and rising medical costs. Even heavyweights ...